{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T00:07:05Z","timestamp":1758931625877,"version":"3.44.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-025-05488-5","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:37:22Z","timestamp":1758883042000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adequate hemodialysis does not compromise the cardioprotective effect of agalsidase alfa on patients with Fabry disease: a case report"],"prefix":"10.1186","volume":"19","author":[{"given":"Xiansen","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4749-1009","authenticated-orcid":false,"given":"Wenge","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"5488_CR1","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/ejhf.1960","volume":"22","author":"A Linhart","year":"2020","unstructured":"Linhart A, Germain DP, Olivotto I, Akhtar MM, Anastasakis A, Hughes D, et al. An expert consensus document on the management of cardiovascular manifestations of Fabry disease. Eur J Heart Fail. 2020;22:1076\u201396.","journal-title":"Eur J Heart Fail"},{"key":"5488_CR2","first-page":"321","volume":"60","author":"Chinese Fabry Disease Expert Panel","year":"2021","unstructured":"Chinese Fabry Disease Expert Panel. Expert consensus for diagnosis and treatment of Fabry disease in China (2021). Zhonghua Nei Ke Za Zhi. 2021;60:321\u201330.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"5488_CR3","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines. J Am Coll Cardiol. 2022;79:e263\u2013421.","journal-title":"J Am Coll Cardiol"},{"key":"5488_CR4","first-page":"337","volume":"37","author":"CL Hung","year":"2021","unstructured":"Hung CL, Wu YW, Lin CC, Lai CH, Jyh-Ming Juang J, et al. 2021 TSOC expert consensus on the clinical features, diagnosis, and clinical management of cardiac manifestations of Fabry disease. Acta Cardiol Sin. 2021;37:337\u201354.","journal-title":"Acta Cardiol Sin"},{"key":"5488_CR5","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s13023-022-02392-9","volume":"17","author":"M Beck","year":"2022","unstructured":"Beck M, Ramaswami U, Hernberg-St\u00e5hl E, Hughes DA, Kampmann C, Mehta AB, et al. Twenty years of the Fabry Outcome Survey (FOS): insights, achievements, and lessons learned from a global patient registry. Orphanet J Rare Dis. 2022;17:238.","journal-title":"Orphanet J Rare Dis"},{"key":"5488_CR6","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.2147\/DDDT.S249433","volume":"14","author":"R Parini","year":"2020","unstructured":"Parini R, Pintos-Morell G, Hennermann JB, Hsu TR, Karabul N, Kalampoki V, FOS Study Group, et al. Analysis of renal and cardiac outcomes in male participants in the Fabry outcome survey starting agalsidase alfa enzyme replacement therapy before and after 18\u00a0years of age. Drug Des Devel Ther. 2020;14:2149\u201358.","journal-title":"Drug Des Devel Ther"},{"key":"5488_CR7","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1093\/ndt\/gfm813","volume":"23","author":"R Mignani","year":"2008","unstructured":"Mignani R, Feriozzi S, Pisani A, Cioni A, Comotti C, Cossu M, et al. Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy. Nephrol Dial Transplant. 2008;23:1628\u201335.","journal-title":"Nephrol Dial Transplant"},{"key":"5488_CR8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/joim.12077","volume":"274","author":"F Weidemann","year":"2013","unstructured":"Weidemann F, Niemann M, St\u00f6rk S, Breunig F, Beer M, Sommer C, et al. Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications. J Intern Med. 2013;274:331\u201341.","journal-title":"J Intern Med"},{"key":"5488_CR9","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1093\/ndt\/gfm096","volume":"22","author":"GM Pastores","year":"2007","unstructured":"Pastores GM, Boyd E, Crandall K, Whelan A, Piersall L, Barnett N. Safety and pharmacokinetics of agalsidase alfa in patients with Fabry disease and end-stage renal disease. Nephrol Dial Transplant. 2007;22:1920\u20135.","journal-title":"Nephrol Dial Transplant"},{"key":"5488_CR10","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1056\/NEJM200303203481224","volume":"348","author":"S Waldek","year":"2003","unstructured":"Waldek S. PR interval and the response to enzyme-replacement therapy for Fabry\u2019s disease. N Engl J Med. 2003;348:1186\u20137.","journal-title":"N Engl J Med"},{"key":"5488_CR11","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/echo.12216","volume":"30","author":"MC Saccheri","year":"2013","unstructured":"Saccheri MC, Cianciulli TF, Lax JA, Gagliardi JA, C\u00e1ceres GL, Quarin AE, et al. Two-dimensional speckle tracking echocardiography for early detection of myocardial damage in young patients with Fabry disease. Echocardiography. 2013;30:1069\u201377.","journal-title":"Echocardiography"},{"key":"5488_CR12","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1093\/eurheartj\/eht098","volume":"34","author":"J Kr\u00e4mer","year":"2013","unstructured":"Kr\u00e4mer J, Niemann M, Liu D, Hu K, Machann W, Beer M, et al. Two-dimensional speckle tracking as a non-invasive tool for identification of myocardial fibrosis in Fabry disease. Eur Heart J. 2013;34:1587\u201396.","journal-title":"Eur Heart J"},{"key":"5488_CR13","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1007\/s00330-022-09183-7","volume":"33","author":"MC Halfmann","year":"2023","unstructured":"Halfmann MC, Altmann S, Schoepf UJ, Reichardt C, Hennermann JB, Kreitner KF, et al. Left atrial strain correlates with severity of cardiac involvement in Anderson-Fabry disease. Eur Radiol. 2023;33:2039\u201351.","journal-title":"Eur Radiol"},{"key":"5488_CR14","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.echo.2013.08.024","volume":"26","author":"AC Boyd","year":"2013","unstructured":"Boyd AC, Lo Q, Devine K, Tchan MC, Sillence DO, Sadick N, et al. Left atrial enlargement and reduced atrial compliance occurs early in Fabry cardiomyopathy. J Am Soc Echocardiogr. 2013;26:1415\u201323.","journal-title":"J Am Soc Echocardiogr"},{"key":"5488_CR15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.echo.2016.10.014","volume":"30","author":"M Pichette","year":"2017","unstructured":"Pichette M, Serri K, Pag\u00e9 M, Di LZ, Bichet DG, Poulin F. Impaired left atrial function in Fabry disease: a longitudinal speckle-tracking echocardiography study. J Am Soc Echocardiogr. 2017;30:170\u20139.","journal-title":"J Am Soc Echocardiogr"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05488-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-025-05488-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05488-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:37:23Z","timestamp":1758883043000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-025-05488-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5488"],"URL":"https:\/\/doi.org\/10.1186\/s13256-025-05488-5","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"6 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Written informed consents were obtained from the patients for publication of this case report and any accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"453"}}